ATE333517T1 - Verfahren und sondenset zur erkennung von krebs - Google Patents

Verfahren und sondenset zur erkennung von krebs

Info

Publication number
ATE333517T1
ATE333517T1 AT00301762T AT00301762T ATE333517T1 AT E333517 T1 ATE333517 T1 AT E333517T1 AT 00301762 T AT00301762 T AT 00301762T AT 00301762 T AT00301762 T AT 00301762T AT E333517 T1 ATE333517 T1 AT E333517T1
Authority
AT
Austria
Prior art keywords
detecting cancer
probe set
chromosomal probes
biological sample
cells
Prior art date
Application number
AT00301762T
Other languages
English (en)
Inventor
Kevin C Halling
Robert B Jenkins
Walter King
Irina A Sokolova
Steven A Seelig
Original Assignee
Vysis Inc
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vysis Inc, Mayo Foundation filed Critical Vysis Inc
Application granted granted Critical
Publication of ATE333517T1 publication Critical patent/ATE333517T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/16—Assays for determining copy number or wherein the copy number is of special importance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT00301762T 1999-03-05 2000-03-03 Verfahren und sondenset zur erkennung von krebs ATE333517T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/264,149 US6174681B1 (en) 1999-03-05 1999-03-05 Method and probe set for detecting cancer

Publications (1)

Publication Number Publication Date
ATE333517T1 true ATE333517T1 (de) 2006-08-15

Family

ID=23004816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00301762T ATE333517T1 (de) 1999-03-05 2000-03-03 Verfahren und sondenset zur erkennung von krebs

Country Status (7)

Country Link
US (9) US6174681B1 (de)
EP (2) EP1650313B1 (de)
JP (4) JP4986316B2 (de)
AT (1) ATE333517T1 (de)
DE (1) DE60029369T2 (de)
DK (1) DK1650313T3 (de)
ES (1) ES2528180T3 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0878552A1 (de) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molekularer Nachweis von chromosomalen Veränderungen
AU3516899A (en) 1998-05-04 1999-11-23 Dako A/S Method and probes for the detection of chromosome aberrations
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
US6797471B2 (en) * 2000-08-04 2004-09-28 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
US20030087248A1 (en) * 2001-02-20 2003-05-08 Morrison Larry E. Methods and probes for the detection of cancer
US6977162B2 (en) * 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
NZ535044A (en) * 2002-03-01 2008-12-24 Ravgen Inc Non-invasive method to determine the genetic sequence of foetal DNA from a sample from a pregnant female thereby detecting any alternation in gene sequence as compared with the wild type sequence
US20070178478A1 (en) * 2002-05-08 2007-08-02 Dhallan Ravinder S Methods for detection of genetic disorders
US7727720B2 (en) * 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
US7442506B2 (en) * 2002-05-08 2008-10-28 Ravgen, Inc. Methods for detection of genetic disorders
US7217515B2 (en) * 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
US7267648B2 (en) * 2003-03-31 2007-09-11 Olympus Corporation Magnifying image pickup unit for an endoscope, an endoscope for in vivo cellular observation that uses it, and endoscopic, in vivo cellular observation methods
US20040197839A1 (en) * 2003-04-04 2004-10-07 Bioview Ltd. Methods of detecting cancer cells in biological samples
US20040248107A1 (en) * 2003-06-09 2004-12-09 Sokolova Irina A. Detection of high grade dysplasia in cervical cells
WO2005001137A2 (en) 2003-06-09 2005-01-06 Vysis, Inc. Detection of high grade dysplasia in cervical cells
US7252946B2 (en) * 2004-01-27 2007-08-07 Zoragen, Inc. Nucleic acid detection
US7828814B2 (en) 2004-08-27 2010-11-09 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20060047337A1 (en) * 2004-08-27 2006-03-02 Brenneman Rodney A Device and method for establishing an artificial arterio-venous fistula
US9706997B2 (en) * 2004-08-27 2017-07-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
EP1809763A2 (de) * 2004-08-31 2007-07-25 Board of Regents, The University of Texas System Diagnose und prognose von krebs auf der grundlage der auf zytologischen präparaten gemessenen telomerlänge
US8226592B2 (en) 2004-12-15 2012-07-24 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US8034577B2 (en) 2005-02-18 2011-10-11 Mayo Foundation For Medical Education And Research Methods and probes for detecting esophageal cancer
WO2006098978A1 (en) 2005-03-09 2006-09-21 Abbott Laboratories Diagnostics method for identifying candidate patients for the treatment with trastuzumab
US20070059747A1 (en) 2005-09-02 2007-03-15 Regents Of The University Of California Methods and probe combinations for detecting melanoma
WO2007087612A2 (en) * 2006-01-25 2007-08-02 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
US20080026366A1 (en) * 2006-06-07 2008-01-31 Newcomer Supply, Inc. Biological fixative and method of using the biological fixative
US7960110B2 (en) 2006-11-15 2011-06-14 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
US20090215643A1 (en) * 2007-07-26 2009-08-27 Cellay, Llc Highly Visible Chromosome-Specific Probes and Related Methods
US20090258365A1 (en) 2008-03-25 2009-10-15 Terstappen Leon W M M METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
US20090280491A1 (en) * 2008-03-27 2009-11-12 The Trustees Of Columbia University In The City Of New York Predicting cancer invasiveness
WO2010039862A1 (en) * 2008-09-30 2010-04-08 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
US8785131B2 (en) * 2008-11-11 2014-07-22 Abbott Laboratories Prognostic test for early stage non small cell lung cancer (NSCLC)
FR2938269B1 (fr) * 2008-11-13 2012-09-28 Array Genomics Procede de detection urinaire du cancer de la vessie
US20100129796A1 (en) * 2008-11-24 2010-05-27 Micah Halpern Dye probe fluorescence resonance energy transfer genotyping
EP2494071A1 (de) * 2009-10-26 2012-09-05 Abbott Laboratories Diagnoseverfahren zur bestimmung der prognose von nicht-kleinzelligem bronchialkarzinom
CA2777169C (en) * 2009-10-26 2018-11-20 Abbott Laboratories Diagnostic methods for determining prognosis of non-small cell lung cancer
DE102011100242A1 (de) 2011-05-02 2012-11-08 Zytovision Gmbh Verfahren zur Detektion von Chromosomenaberration
EP2798079B1 (de) 2011-12-30 2016-09-07 Abbott Molecular Inc. Materialien und verfahren zur diagnose von blasenkrebs und zur überwachung des erneuten auftretens davon
CA2929471C (en) * 2012-11-09 2022-04-19 The Regents Of The University Of California Methods for predicting age and identifying agents that induce or inhibit premature aging
WO2015125027A2 (en) 2014-02-12 2015-08-27 Leica Biosystems Newcastle Ltd. Kit and method for detecting bladder cancer
ES2702603T3 (es) 2015-06-23 2019-03-04 Zytovision Gmbh Procedimiento para la detección de aberraciones cromosómicas
EP3130680A1 (de) 2015-08-11 2017-02-15 Universitat de Girona Verfahren zur detektion, nachverfolgung und/oder klassifikation von darmerkrankungen
US11795512B2 (en) 2018-01-30 2023-10-24 Board Of Regents, The University Of Texas System Multi-color fish test for bladder cancer detection
WO2021034537A1 (en) 2019-08-22 2021-02-25 Edwards Lifesciences Corporation Puncture needles
CN114727836B (zh) 2019-11-14 2026-01-09 爱德华兹生命科学公司 经导管的医疗植入物递送
US12527942B2 (en) 2021-02-01 2026-01-20 Edwards Lifesciences Corporation Pulmonary vein shunting
WO2025125682A1 (en) 2023-12-15 2025-06-19 Vib Vzw Means and methods to classify the gut microbiome

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US5756696A (en) * 1986-01-16 1998-05-26 Regents Of The University Of California Compositions for chromosome-specific staining
US5028525A (en) * 1986-11-24 1991-07-02 Regents Of The University Of California Method of preparing and applying single stranded DNA probes to double stranded target DNAs in situ
US5874234A (en) * 1990-08-01 1999-02-23 Johns Hopkins University Assay for a novel mammalian protein associated with uncontrolled cell division
US5491224A (en) 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
DE69330750T2 (de) * 1992-03-04 2002-07-04 The Regents Of The University Of California, Oakland Vergleichende genomhybridisierung
AU5355594A (en) 1992-10-09 1994-05-09 Oncor, Inc. Methods for the detection of chromosome structural abnormalities by (in situ) hybridization to fixed tissue
AU1094795A (en) * 1993-11-12 1995-05-29 Oncor, Inc. Detection of bladder cancer
NZ284612A (en) * 1994-03-18 1997-09-22 Univ Utah Res Found Multiple tumour suppressor (mts) gene and its use in the diagnosis and treatment of cancer
EP0879297A4 (de) 1995-12-22 2003-04-16 Biorad Lab Inc Verfahren und gerät zur durchführung von fluoreszenz in situ hybridisierung unter messung einer vielzahl von parametern
US5759781A (en) * 1995-12-22 1998-06-02 Yale University Multiparametric fluorescence in situ hybridization
GB9704054D0 (en) * 1997-02-27 1997-04-16 Univ Cambridge Tech Assay
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer

Also Published As

Publication number Publication date
EP1650313A1 (de) 2006-04-26
JP2000270900A (ja) 2000-10-03
US9790558B2 (en) 2017-10-17
JP2017131248A (ja) 2017-08-03
US6174681B1 (en) 2001-01-16
JP2015015958A (ja) 2015-01-29
DE60029369D1 (de) 2006-08-31
US20150337391A1 (en) 2015-11-26
US6376188B1 (en) 2002-04-23
US7998670B2 (en) 2011-08-16
US8785129B2 (en) 2014-07-22
DE60029369T2 (de) 2007-07-12
US20130316344A1 (en) 2013-11-28
US20120276540A1 (en) 2012-11-01
JP2011224021A (ja) 2011-11-10
DK1650313T3 (en) 2015-01-26
EP1035215A3 (de) 2000-09-20
EP1650313B1 (de) 2014-11-05
US7232655B2 (en) 2007-06-19
US20080032302A1 (en) 2008-02-07
US20110177510A1 (en) 2011-07-21
EP1035215A2 (de) 2000-09-13
US20150072884A1 (en) 2015-03-12
ES2528180T3 (es) 2015-02-05
JP4986316B2 (ja) 2012-07-25
JP5680502B2 (ja) 2015-03-04
US9045802B2 (en) 2015-06-02
EP1035215B1 (de) 2006-07-19
US20020160409A1 (en) 2002-10-31
JP6170024B2 (ja) 2017-07-26

Similar Documents

Publication Publication Date Title
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
ATE350488T1 (de) Verfahren und testsysteme zur identifizierung von elite event gat-zm1 in biologischen proben
DK0979308T3 (da) Fremgangsåde til fremstilling af et diagnostisk standard gen-transkriptmönster
WO2000077260A8 (en) Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
DE69732667D1 (de) Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
DE59802771D1 (de) Vorrichtung und verfahren zur gewinnung und erst-aufbereitung von gewebeproben für die molekulargenetische diagnostik
DE69427103D1 (de) Verfahren, Reagenzien und Kits zur Untersuchung von Neisseria gonorrhoeae und Chlamydia trachomatis
DE50106565D1 (de) Verfahren zur Identifizierung von zellspezifischen Zielstrukturen
DE50011820D1 (de) Verfahren zur kultivierung von krebszellen aus humangewebe und vorrichtung zur aufbereitung von gewebeproben
ATE251222T1 (de) Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
DE69941044D1 (de) Methoden, Apparat und Computerprogramm zur quantitativen Bestimmung von Nukleinsäurensequenzen in Proben unter Verwendung von Standardkurven und Abschätzungen von Amplifikationsverhältnissen
DE69632252D1 (de) Verfahren zur erkennung von klonalen populationen von transformierten zellen in einer genomisch heterogenen zellulären probe
EP1390523A4 (de) Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker
DE60142898D1 (de) Diagnostisches kit zur identifikation und feststellung von wirkstoffresistenz bei mykobakterium sowie herstellungsmethoden davon
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
ATE426043T1 (de) Verfahren zur identifizierung des brustkrebsrisikos
ATE557098T1 (de) Nachweis hochgradiger dysplasie in zervixzellen
DE69630142D1 (de) Verfahren zur identifizierung metastatischer sequenzen
DE50204289D1 (de) Vorrichtung und verfahren zur selektion von selbstbeweglichen biologischen spezies, insbesondere von samenzellen
DE60332378D1 (de) Polynukleotide zur amplifikation undzum nachweis von chlamydia trachomatis und neisseria gonorrhoeae
DE60130970D1 (de) Reagenziensatz zur detektion von mikroorganismen, vorrichtung zur quantifizierungvon mikroorganismen und verfahren zur quantifizierung von mikroorganismen
ATE412053T1 (de) Verfahren zum nachweis von krebs
ATE494390T1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties